What screening and surveillance steps are recommended for a first-degree relative of a patient with familial adenomatous polyposis?

Screening for First-Degree Relatives of FAP Patients

First-degree relatives of a patient with familial adenomatous polyposis should undergo genetic counseling and predictive testing for the familial APC mutation, followed by sigmoidoscopy or colonoscopy starting at age 10-12 years and repeated every 1-2 years if they carry the mutation. 1

Genetic Testing Strategy

The initial step is genetic counseling and mutation analysis for all first-degree relatives once a pathogenic APC mutation has been identified in the index patient 2. This approach allows for:

• Risk stratification: Relatives who test negative for the familial mutation can return to average-risk screening protocols
• Early intervention: Mutation carriers can begin appropriate surveillance before polyp development
• Predictive testing should be offered from age 10-12 years onwards 3, coinciding with the recommended age to begin endoscopic surveillance

Endoscopic Surveillance Protocol for Mutation Carriers

Classical FAP

For relatives confirmed to carry an APC mutation:

• Start sigmoidoscopy or colonoscopy at age 10-11 years 1
• Repeat every 1-2 years until adenomas are detected 2, 1
• Once adenomas appear, increase to annual colonoscopy until colectomy is planned 1
• Continue lifelong surveillance even after colectomy 1

The rationale for starting at age 10-12 is based on evidence showing CRC risk before age 20 is very low in FAP 2, but polyps typically begin developing in the early teens.

Attenuated FAP (AFAP)

If the family has attenuated FAP (fewer polyps, later onset):

• Begin colonoscopy at age 18-20 years 1
• Repeat every 1-2 years 1
• Annual colonoscopy once adenomas are detected

Upper Gastrointestinal Surveillance

Upper endoscopy screening should begin at age 25-30 years or when colorectal polyposis is diagnosed, whichever comes first 1. This addresses the significant risk of duodenal and gastric adenomas, which occur in almost all FAP patients 4.

• Use both front-viewing and side-viewing endoscopes for adequate ampullary visualization 1
• Surveillance intervals depend on Spigelman staging of duodenal polyposis 1

Extracolonic Manifestations Screening

When colorectal polyposis is diagnosed or at age 25-30 years, consider screening for 1:

• Thyroid cancer: Annual cervical ultrasonography may be considered
• Desmoid tumors: Baseline CT or MRI if risk factors present (positive family history for desmoids, specific APC mutation sites)

Critical Pitfalls to Avoid

1. Do not delay genetic testing: Waiting until symptoms develop defeats the purpose of predictive testing and early intervention
2. Do not use colonoscopy alone in young children: Sigmoidoscopy is adequate initially since polyps typically develop throughout the colon
3. Do not stop surveillance after colectomy: Rectal remnants, pouches, and upper GI tract require ongoing monitoring 1
4. Do not overlook upper GI surveillance: Duodenal cancer is the second leading cause of death after colectomy 5

Evidence Quality Considerations

The 2015 ASCO endorsement of ESMO guidelines 1 provides the most comprehensive and recent guideline-level recommendations, building upon the foundational 2008 Gut guidelines 2. The 2024 updated European guidelines 6 achieved high consensus (≥80%) on these surveillance protocols, reinforcing their validity. Surveillance has been shown to reduce CRC-associated mortality in FAP patients through early detection and prophylactic intervention 2.

The recommendation for referral to specialized centers is emphasized across guidelines 6, given the complexity of managing this rare disease and the need for coordinated multidisciplinary care.